Mobile Stroke Unit Market - Forecast(2024 - 2030)

Mobile Stroke Unit Market size is estimated to reach $12.8 billion by 2027, growing at a CAGR of 7.4% during the forecast period 2022-2027. The Mobile Stroke Treatment Unit (MSTU) is an emergency vehicle planned to offer instant, specialized care to people who may be having a stroke bringing progressive technologies, specialist staff, and lifesaving stroke treatment to more people in need. Former investigations have shown that mobile stroke units (MSUs) are related to faster tissue plasminogen activator (tPA) treatment times in acute ischemic stroke than traditional ambulance transport succeeded by treatment in emergency departments. The mobile stroke unit at UC Health is progressive stroke care on the move bringing the fortitude of the UC Health stroke team directly to the patient when seconds matter most. The mobile stroke unit comes outfitted with a computed tomography scanner to assist in diagnosing a stroke as well as the ability to commence treatment prior to the patient appearing at the hospital. A Transient Ischemic Attack (TIA), also termed Transient Cerebral Ischemia or “mini-stroke,” is an event in which blood flow to the brain is briefly blocked and then restored prior to lasting damage happening. Surgical treatment of the underlying cause may avert permanent damage. The most typical treatment options are carotid endarterectomy (CEA) and carotid artery angioplasty and stenting (CAS).

The expanding population of the elderly and the rising pervasiveness of stroke conditions including transient ischemic attacks are set to drive the Mobile Stroke Unit Market. The current technological progress in the healthcare sector is set to propel the growth of the Mobile Stroke Unit Market during the forecast period 2022-2027. This represents the Mobile Stroke Unit Industry Outlook.

Report Coverage

The report: “Mobile Stroke Unit Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the Mobile Stroke Unit Market.

By Product: Computed Tomography Scanner, Conventional Emergency Equipment, Telemedicine System, Automated Image Analysis, POC Laboratory System, Others.
By Type: Frazer Mobile Stroke Unit, Demers Mobile Stroke Unit, Others.
By Geography: North America (U.S, Canada and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia, Rest of South America), and Rest Of The World (Middle East, Africa).

Key Takeaways

• Geographically, North America Mobile Stroke Unit Market accounted for the highest revenue share in 2021 and it is poised to dominate the market over the period 2022-2027 owing to the boost in the application of most recent technologies in the medical sector involving products like computed tomography scanner and the longer life expectancy in the North American region.
• Mobile Stroke Unit Market growth is being driven by the increasing predominance of stroke conditions including transient ischemic attack, the different awareness programs undertaken by the government organizations, and research funds accepted by research universities for a superior contribution towards prevention, and diagnosis and treatment of stroke. However, the disadvantages in Mobile Stroke Treatment Units (MSTU) care as per investigations conducted have been found to be associated with restraints of resources and involved errors in weight-based intravenous thrombolysis (IVtPA) dosing, inability to administer IVtPA, or reversal for anti-coagulation related hemorrhage and these are some of the major factors hampering the growth of Mobile Stroke Unit Market. 
• Mobile Stroke Unit Market Detailed Analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Mobile Stroke Unit Market report. 

Mobile Stroke Unit Market Segment Analysis – By Product

The Mobile Stroke Unit Market based on products can be further segmented into Computed Tomography Scanner, Conventional Emergency Equipment, Telemedicine systems, Automated Image Analysis, POC Laboratory Systems, and Others. The Computed Tomography Scanner Segment held the largest market share in 2021. This growth is owing to the surging application of computed tomography scanners to detect ailments and injuries. As per the Centers For Disease Control And Prevention (CDC), a transient ischemic attack (TIA) is a warning sign of a future stroke. The proliferating application of computed tomography scanner to decide whether a patient endured a transient ischemic attack or hemorrhagic stroke is further propelling the growth of the Computed Tomography Scanner segment.

Furthermore, the Telemedicine System segment is estimated to grow with the fastest CAGR of 8.1% during the forecast period 2022-2027 owing to the heightening application of telemedicine by healthcare professionals to permit the physicians to beam into the ambulance, evaluate the patient, carry out a tele-examination and communicate with the family of the patient and ambulance crew for treatment of stroke conditions like a transient ischemic attack.

Mobile Stroke Unit Market Segment Analysis – By Type

The Mobile Stroke Unit Market based on type can be further segmented into Frazer Mobile Stroke Unit, Demers Mobile Stroke Unit, and Others. The Demers Mobile Stroke Unit Segment held the largest market share in 2021. This growth is owing to the surging application of Demers mobile stroke unit for stroke treatment and the computed tomography scanner, permitting emergency medical technicians to communicate greater information regarding their patients. The Demers Mobile Stroke Unit is an award-winning type I ambulance that provides space for progressive diagnostics and a computed tomography (CT) scanner. The ambulance is outfitted with exclusive design features, inclusive of an on-board generator, integrated telemedicine, dual compartment door seals, and more which are further propelling the growth of this segment.

Furthermore, the Frazer Mobile Stroke Unit segment is estimated to grow with the fastest CAGR of 8.2% during the forecast period 2022-2027 owing to the extensive application of Frazer mobile stroke unit which permits stroke teams to diagnose patients up to an hour quicker than would happen at the time of a normal ambulance call for treating stroke conditions including transient ischemic attack.

Mobile Stroke Unit Market Segment Analysis – By Geography

The Mobile Stroke Unit Market based on geography can be further segmented into North America, Europe, Asia-Pacific, South America and Rest of the World. North America (Mobile Stroke Unit Market) held the largest share with 35% of the overall market in 2021. The growth of this region is owing to the increasing predominance of stroke conditions and the surging count of mobile stroke treatment units (MSTUs) operational in the North American region. As per the Centers For Disease Control And Prevention (CDC), as many as 10% to 15% of people will have an important stroke within 3 months of a transient ischemic attack (TIA). The soaring growth potential for mobile stroke units in the U.S. owing to the extensive research financing and the numerous initiatives and programs at the country-wide level to increase the awareness among people associated with the primary stroke signs is further propelling the growth of the Mobile Stroke Unit Market in the North American region.

Furthermore, the Asia-Pacific region is estimated to be the region with the fastest CAGR over the forecast period 2022-2027. This growth is owing to factors like the increasing predominance of stroke conditions which may include transient ischemic attack (TIA) in the Asia-Pacific region. Apart from stroke conditions, the rising pervasiveness of obesity in countries like India, China, Japan, and South Korea is further fuelling the progress of the Mobile Stroke Unit Market in the Asia-Pacific region.

Mobile Stroke Unit Market Drivers

Surging Applications Of Computed Tomography Scanner Are Projected To Drive The Growth Of Mobile Stroke Unit Market:

As per everydayhealth website, researchers checked data from 1,047 patients who had an ischemic stroke and were treated at seven medical centers all through the U.S. between 2014 and 2020, inclusive of Houston; New York City; Los Angeles; Memphis; Aurora, Colorado; Indianapolis; and Burlingame, California. In all, 617 patients were treated through mobile stroke units, and 430 accepted standard ambulance emergency care. The outcomes demonstrated that overall, 97 percent of patients treated in a mobile stroke unit accepted tPA, in comparison with 80 percent of those transported to the hospital by a standard ambulance. Computed tomography (CT) is a priceless tool in the diagnosis of numerous clinical conditions. Portable or mobile CT is specifically useful in reviewing crucially sick, intensive care unit patients by scanning at the bedside. A paradigm shift in the application of mobile CT was its installation in ambulances for the management of acute stroke. Given the time-sensitive character of acute ischemic stroke, Mobile stroke units (MSU) was established in Germany including an ambulance outfitted with a CT(Computed Tomography) scanner, a point of care laboratory system, together with teleradiological backing. In a fundamental reconfiguration of stroke care, the MSU would bring the CT scanner to the stroke patient, without awaiting the patient at the emergency room. Two disconnected MSU projects in Saarland and Berlin showed the security and feasibility of this concept for prehospital stroke care, demonstrating the raised rate of intravenous thrombolysis and a considerable decline in time to treatment compared to conventional care. MSU also enhanced the triage of patients to suitable and specialized hospitals. The surging applications of Computed Tomography Scanner are therefore fuelling the growth of the Mobile Stroke Unit Market during the forecast period 2022-2027.

Proliferating Benefits Of Application Of Mobile Stroke Unit For Acute Ischemic Stroke Management Are Expected To Boost The Growth Of The Mobile Stroke Unit Market:

As per Centers For Disease Control And Prevention (CDC), a transient ischemic attack (TIA) is at times termed a “mini-stroke.” It is distinct from the principal kinds of stroke, owing to blood flow to the brain being blocked for only a short time—normally no more than 5 minutes. More than a third of people who have a TIA and do not get treatment to have a major stroke within 1 year. A systematic review and meta-analysis pertaining to the comparison of mobile stroke unit (MSU) with typical care for acute ischemic stroke management indicated that MSU application was importantly related to a nearly 65% increase in the odds of the superior outcome at 90 days after adjustment for potential confounders, a higher proportion of intravenous thrombolysis, and a decrease of half an hour in onset-to-thrombolysis time, without safety concerns. The proliferating benefits of the application of Mobile Stroke Unit for Acute Ischemic Stroke Management are therefore driving the growth of the Mobile Stroke Unit  Market during the forecast period 2022-2027.

Mobile Stroke Unit Market Challenges

Reimbursement Disadvantages Of Mobile Stroke Unit Are Hampering The Growth Of The Mobile Stroke Unit Market:

Mobile stroke units — ambulances outfitted to offer accelerated stroke diagnosis and treatment — record financial hardships owing to restricted reimbursement from health care insurers. Almost all mobile stroke units in the U.S. reveal that they rely upon private gifts, grants, or institutional backing for funding. Ambulances with specialized staff and equipment to offer accelerated stroke treatment record financial hardships owing to restricted reimbursement from health care insurers, as per preliminary research to be presented at the American Stroke Association’s International Stroke Conference 2021. The virtual meeting was scheduled to be held on March 17-19, 2021, and is a world premiere meeting for researchers and clinicians committed to the science of stroke and brain health. As per the most current comprehensive data from the Centers for Disease Control and Prevention (CDC), stroke is the fifth leading cause of demise in the U.S. and a principal contributor to long-term disability. However, mobile stroke units are not extensively accessible, in part owing to there being no established means for the government or insurance firms to reimburse the costs of care offered by mobile stroke units, specifically when specialized tests (CT (Computed Tomography) scans requiring application of computed tomography scanner and so on) and medications are administered outside of a hospital. By way of a blinded survey, researchers accumulated information in June 2019 (to reflect the former12 months of their operation) from all 20 U.S. mobile stroke unit programs. Of the 19 units that responded, 18 recorded negative financial status while one, categorized as an outpatient clinic and not an ambulance, recorded a positive financial status. All mobile stroke programs rely at least partly on funding from personal gifts, grants or institutional support owing to billing limits from health care insurers. These issues are thus hampering the growth of the Mobile Stroke Unit  Market.

Mobile Stroke Unit Industry Outlook:

Product launches, mergers and acquisitions, joint ventures, research initiatives, technological advancements and geographical expansions are key strategies adopted by players in the Mobile Stroke Unit Market. Key companies of this market are:

1. MEYTEC GmbH Informationssysteme
   
2. NeuroLogica
3. Excellance, Inc.
4. Frazer Ltd.
5. FalckA/S
6. Demers
7. Tri-Star Industries Ltd.
8. Jesai Healthcare Pvt. Ltd.
9. Cleveland Clinic
10. Kovai Medical Center

Recent Developments

• In May 2021, the University Medical Center in El Paso revealed a Mobile Stroke Unit. UMC is the only Joint Commission-certified Level 1 Comprehensive Stroke Center of El Paso. The Mobile Stroke Unit enhances UMC’s capacity for care in a fast-growing region.
• In March 2021, NeuroLogica declared the introduction of its novel SmartMSU™ with OmniTom® Elite CT scanner. This next-generation Mobile Stroke Unit (MSU) promotes the technology accessible for stroke imaging on an ambulance that the firm pioneered 10 years ago. The OmniTom® Elite multi-slice computed tomography (CT) boasts a tiny footprint and high-resolution image quality.
• In November 2020, the Santa Lúcia Hospital Network, the fourth-biggest private hospital group in Brazil, became the earliest medical site in the country to provide the potentially life-saving advantages of mobile stroke evaluation and early intervention to patients, succeeding its purchase of the Samsung NeuroLogica Mobile Stroke Unit. Outfitted with a CereTom Elite 8-slice mobile head CT scanner, the hospital system’s Mobile Unit maneuvers effortlessly to private homes, nursing homes, as well as more difficult-to-reach settings, allowing physicians to image stroke patients at the time of or immediately succeeding an event to evaluate the nature of the stroke and administer clot-busting tPA (tissue plasminogen activator) for ischemic events. The NeuroLogica CereTom Elite conveys high-quality non-contrast, angiography, and contrast perfusion scans.

Related Reports

Stroke Management Market - Forecast 2021 - 2026

Report Code: HCR 71978

Acute Ischemic Stroke Diagnosis Market - Forecast 2021 - 2026

Report Code: HCR 85955

3D Mobile Mapping Market - Forecast(2022 - 2027)

Report Code: ESR 0517

 For more Lifesciences and Healthcare Market reports, please click here